N. Nicolas

Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry

Dominique Salmon‐Céron, Florence Tubach, Olivier Lortholary et al. · Annals of the Rheumatic Diseases · 2010 · 283 citations

Medicine, Immunology, Pharmacotherapy +11

Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults.

Luc Mouthon, Alberto Nóbrega, N. Nicolas et al. · Proceedings of the National Academy of Sciences · 1995 · 168 citations

Life Sciences, Developmental Biology, Immunology +17

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Sclerotherapy using Surgiflo and alcohol: A new alternative for the treatment of aneurysmal bone cysts

Ismat Ghanem, N. Nicolas, Maroun Rizkallah et al. · Journal of Children s Orthopaedics · 2017 · 26 citations · Full text

Medicine, Radiology, Surgery +15